Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies
Titel:
Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies
Auteur:
Stuver, Robert Shah, Gunjan L. Korde, Neha S. Roeker, Lindsey E. Mato, Anthony R. Batlevi, Connie L. Chung, David J. Doddi, Sital Falchi, Lorenzo Gyurkocza, Boglarka Hamilton, Audrey Lin, Ya-Hui Jakubowski, Ann A. Joffe, Erel Landau, Heather L. Lin, Richard J. Mailankody, Sham Palomba, M. Lia Park, Jae H. Perales, Miguel-Angel Ponce, Doris M. Ramanathan, Lakshmi V. Salles, Gilles A. Scordo, Michael Seo, Susan K. Shah, Urvi A. Stein, Eytan M. Straus, David Usmani, Saad Z. Young, James W. Zelenetz, Andrew D. Noy, Ariela Vardhana, Santosha A.